One Step Vending Corp. (KOSK)
USD 0.0
(-3.92%)
USD 0.0
(-3.92%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -26.55 Thousand USD | -27.83% |
| 2022 | -20.76 Thousand USD | 72.87% |
| 2021 | -76.55 Thousand USD | -46.99% |
| 2020 | -52.07 Thousand USD | -600.0% |
| 2019 | -7440.00 USD | 66.62% |
| 2018 | -1.02 Million USD | -184.69% |
| 2017 | 26.32 Thousand USD | 0.0% |
| 2015 | -38.61 Thousand USD | 59.28% |
| 2014 | -94.67 Thousand USD | -27924.76% |
| 2013 | -338.42 USD | 0.0% |
| 2009 | -4897.00 USD | 117.42% |
| 2008 | -67.86 Thousand USD | 92.33% |
| 2007 | -891.25 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -2450.00 USD | 50.54% |
| 2024 Q1 | -4960.00 USD | 63.66% |
| 2023 Q2 | -3330.00 USD | -38.75% |
| 2023 Q1 | -2400.00 USD | 66.43% |
| 2023 Q4 | -13.65 Thousand USD | -186.16% |
| 2023 FY | - USD | -27.83% |
| 2023 Q3 | -4770.00 USD | -43.24% |
| 2022 FY | - USD | 72.87% |
| 2022 Q2 | -7860.00 USD | -70.13% |
| 2022 Q3 | -1150.00 USD | 85.37% |
| 2022 Q4 | -7150.00 USD | -521.74% |
| 2022 Q1 | -4620.00 USD | 21.16% |
| 2021 Q3 | -3480.00 USD | 27.04% |
| 2021 Q4 | -5860.00 USD | -68.39% |
| 2021 Q1 | -62.43 Thousand USD | 0.0% |
| 2021 FY | - USD | -46.99% |
| 2021 Q2 | -4770.00 USD | 92.36% |
| 2020 FY | - USD | -600.0% |
| 2019 FY | - USD | 66.62% |
| 2018 FY | - USD | -184.69% |
| 2017 FY | - USD | 0.0% |
| 2015 FY | - USD | 59.28% |
| 2014 Q2 | -34.53 USD | -1.89% |
| 2014 FY | - USD | -27924.76% |
| 2014 Q3 | -18.49 USD | 46.45% |
| 2014 Q1 | -33.89 USD | 66.82% |
| 2014 Q4 | -7.76 USD | 58.02% |
| 2013 Q3 | -67.58 USD | 25.71% |
| 2013 FY | - USD | 0.0% |
| 2013 Q4 | -102.12 USD | -51.12% |
| 2013 Q2 | -90.96 USD | -19.42% |
| 2013 Q1 | -76.17 USD | 0.0% |
| 2010 Q3 | -49.58 Thousand USD | 37.79% |
| 2010 Q1 | -75.32 Thousand USD | -828.57% |
| 2010 Q2 | -79.69 Thousand USD | -5.8% |
| 2009 FY | - USD | 117.42% |
| 2009 Q4 | 10.33 Thousand USD | 918.62% |
| 2009 Q1 | -314.00 USD | 0.0% |
| 2009 Q3 | 1015.00 USD | 17.61% |
| 2009 Q2 | 863.00 USD | 374.84% |
| 2008 FY | - USD | 92.33% |
| 2007 Q1 | -353.97 Thousand USD | 0.0% |
| 2007 Q2 | -345.24 Thousand USD | 2.47% |
| 2007 FY | - USD | 0.0% |
| 2006 Q2 | -465.26 Thousand USD | -36.66% |
| 2006 Q1 | -340.45 Thousand USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| China Medicine Corporation | 13.27 Million USD | 100.2% |
| DH Enchantment Inc. | -145.23 Thousand USD | 81.717% |
| Exlites Holdings International, Inc. | -90.49 Thousand USD | 70.659% |
| Itonis, Inc. | -38.31 Thousand USD | 30.692% |
| MediPal Holdings Corporation | 431.52 Million USD | 100.006% |
| PD-Rx Pharmaceuticals, Inc. | -51.41 Thousand USD | 48.362% |
| Pharmagen, Inc. | -2.89 Million USD | 99.082% |
| Suzuken Co., Ltd. | 340.78 Million USD | 100.008% |